Tilray, Inc. Series 2 Aktie News

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, has announced plans to expand its medical cannabis operations i...

Tilray stock price surged to the highest point since April last year and then pulled back after its mixed financial results. TLRY's US shares ended the week at $1.72, down by 26% from its highest point this year.

The Canadian cannabis sector continues to attract investors as North American legalization momentum gains strength. Recently, U.S. regulators advanced discussions on cannabis rescheduling, signaling a potential shift toward federal reform. This news lifted optimism across the industry, especially for Canadian producers eyeing future U.S. market entry. Currently, the U.S. cannabis market generat...

Tilray Brands (TLRY -15.95%), the Canadian marijuana stock, closed 22% higher yesterday after reporting a surprise profit for fiscal Q1. That's the good news.

This week marked the start of earnings season with several major companies reporting results, including Delta Air Lines and PepsiCo, while the big banks like JPMorgan Chase, Citigroup, and Wells Fargo are set to report next week. Investors are closely watching these early reports for cues on the broader economic landscape amid ongoing uncertainties.

Tilray reported strong Q1-2026 results with net income and revenue growth, sparking a sector-wide rally in cannabis stocks. Tilray's performance was driven by international and Canadian cannabis sales. I continue a Hold rating due to uncertainty around cannabis rescheduling and recent price surges.

Tilray Brands, Inc. (NASDAQ:TLRY ) Q1 2026 Earnings Call October 9, 2025 8:30 AM EDT Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - President, CEO & Chairman Carl Merton - CFO & Principal Accounting Officer Lloyd Brathwaite - Chief Information Officer Blair MacNeil - President of Tilray Canada Conference Call Participants Aaron Grey - Alliance Global Partner...

Tilray Brands Inc (NASDAQ: TLRY) soared on market open today after coming in ahead of Street estimates for its fiscal Q1, with net income printing at $1.5 million and revenue climbing to a record $210 million. Part of the momentum this morning is related to optimism around cannabis rescheduling under the Trump administration as well.